Home/Filings/4/0001859810-24-000004
4//SEC Filing

Milligan Sandra 4

Accession 0001859810-24-000004

CIK 0000926617other

Filed

Oct 27, 8:00 PM ET

Accepted

Oct 28, 6:54 PM ET

Size

5.9 KB

Accession

0001859810-24-000004

Insider Transaction Report

Form 4
Period: 2024-10-28
Milligan Sandra
Interim CEO
Transactions
  • Award

    Restricted Stock Units

    2024-10-28+20,00020,000 total
    Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Issuer

Aspira Women's Health Inc.

CIK 0000926617

Entity typeother

Related Parties

1
  • filerCIK 0001859810

Filing Metadata

Form type
4
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 6:54 PM ET
Size
5.9 KB